Copyright Reports & Markets. All rights reserved.

Global Visceral Pain Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Visceral Pain Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Visceral Pain Treatment Market Size Growth Rate by Product
      • 1.4.2 HS-665
      • 1.4.3 CC-8464
      • 1.4.4 BLU-5937
      • 1.4.5 APD-371
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Visceral Pain Treatment Market Size Growth Rate by End User
      • 1.5.2 In-patient
      • 1.5.3 Out-patient
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Visceral Pain Treatment Market Size
      • 2.1.1 Global Visceral Pain Treatment Revenue 2014-2025
      • 2.1.2 Global Visceral Pain Treatment Sales 2014-2025
    • 2.2 Visceral Pain Treatment Growth Rate by Regions
      • 2.2.1 Global Visceral Pain Treatment Sales by Regions
      • 2.2.2 Global Visceral Pain Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Visceral Pain Treatment Sales by Manufacturers
      • 3.1.1 Visceral Pain Treatment Sales by Manufacturers
      • 3.1.2 Visceral Pain Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Visceral Pain Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Visceral Pain Treatment Revenue by Manufacturers
      • 3.2.1 Visceral Pain Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Visceral Pain Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Visceral Pain Treatment Price by Manufacturers
    • 3.4 Visceral Pain Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Visceral Pain Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Visceral Pain Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Visceral Pain Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Visceral Pain Treatment Sales by Product
    • 4.2 Global Visceral Pain Treatment Revenue by Product
    • 4.3 Visceral Pain Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Visceral Pain Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Visceral Pain Treatment by Countries
      • 6.1.1 North America Visceral Pain Treatment Sales by Countries
      • 6.1.2 North America Visceral Pain Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Visceral Pain Treatment by Product
    • 6.3 North America Visceral Pain Treatment by End User

    7 Europe

    • 7.1 Europe Visceral Pain Treatment by Countries
      • 7.1.1 Europe Visceral Pain Treatment Sales by Countries
      • 7.1.2 Europe Visceral Pain Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Visceral Pain Treatment by Product
    • 7.3 Europe Visceral Pain Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Visceral Pain Treatment by Countries
      • 8.1.1 Asia Pacific Visceral Pain Treatment Sales by Countries
      • 8.1.2 Asia Pacific Visceral Pain Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Visceral Pain Treatment by Product
    • 8.3 Asia Pacific Visceral Pain Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Visceral Pain Treatment by Countries
      • 9.1.1 Central & South America Visceral Pain Treatment Sales by Countries
      • 9.1.2 Central & South America Visceral Pain Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Visceral Pain Treatment by Product
    • 9.3 Central & South America Visceral Pain Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Visceral Pain Treatment by Countries
      • 10.1.1 Middle East and Africa Visceral Pain Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Visceral Pain Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Visceral Pain Treatment by Product
    • 10.3 Middle East and Africa Visceral Pain Treatment by End User

    11 Company Profiles

    • 11.1 Addex Therapeutics Ltd
      • 11.1.1 Addex Therapeutics Ltd Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Addex Therapeutics Ltd Visceral Pain Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Addex Therapeutics Ltd Visceral Pain Treatment Products Offered
      • 11.1.5 Addex Therapeutics Ltd Recent Development
    • 11.2 Astellas Pharma Inc.
      • 11.2.1 Astellas Pharma Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Astellas Pharma Inc. Visceral Pain Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Astellas Pharma Inc. Visceral Pain Treatment Products Offered
      • 11.2.5 Astellas Pharma Inc. Recent Development
    • 11.3 Chromocell Corporation
      • 11.3.1 Chromocell Corporation Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Chromocell Corporation Visceral Pain Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Chromocell Corporation Visceral Pain Treatment Products Offered
      • 11.3.5 Chromocell Corporation Recent Development
    • 11.4 GIcare Pharma Inc
      • 11.4.1 GIcare Pharma Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 GIcare Pharma Inc Visceral Pain Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 GIcare Pharma Inc Visceral Pain Treatment Products Offered
      • 11.4.5 GIcare Pharma Inc Recent Development
    • 11.5 Grunenthal GmbH
      • 11.5.1 Grunenthal GmbH Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Grunenthal GmbH Visceral Pain Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Grunenthal GmbH Visceral Pain Treatment Products Offered
      • 11.5.5 Grunenthal GmbH Recent Development
    • 11.6 Medestea Research & Production S.p.A.
      • 11.6.1 Medestea Research & Production S.p.A. Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Medestea Research & Production S.p.A. Visceral Pain Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Medestea Research & Production S.p.A. Visceral Pain Treatment Products Offered
      • 11.6.5 Medestea Research & Production S.p.A. Recent Development
    • 11.7 Neurim Pharmaceuticals Ltd
      • 11.7.1 Neurim Pharmaceuticals Ltd Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Products Offered
      • 11.7.5 Neurim Pharmaceuticals Ltd Recent Development
    • 11.8 Pfizer Inc.
      • 11.8.1 Pfizer Inc. Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Pfizer Inc. Visceral Pain Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Pfizer Inc. Visceral Pain Treatment Products Offered
      • 11.8.5 Pfizer Inc. Recent Development

    12 Future Forecast

    • 12.1 Visceral Pain Treatment Market Forecast by Regions
      • 12.1.1 Global Visceral Pain Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Visceral Pain Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Visceral Pain Treatment Market Forecast by Product
      • 12.2.1 Global Visceral Pain Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Visceral Pain Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Visceral Pain Treatment Market Forecast by End User
    • 12.4 North America Visceral Pain Treatment Forecast
    • 12.5 Europe Visceral Pain Treatment Forecast
    • 12.6 Asia Pacific Visceral Pain Treatment Forecast
    • 12.7 Central & South America Visceral Pain Treatment Forecast
    • 12.8 Middle East and Africa Visceral Pain Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Visceral Pain Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Visceral Pain Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Visceral Pain Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Visceral Pain Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Visceral Pain Treatment in these regions.
      This research report categorizes the global Visceral Pain Treatment market by top players/brands, region, type and end user. This report also studies the global Visceral Pain Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Addex Therapeutics Ltd
      Astellas Pharma Inc.
      Chromocell Corporation
      GIcare Pharma Inc
      Grunenthal GmbH
      Medestea Research & Production S.p.A.
      Neurim Pharmaceuticals Ltd
      Pfizer Inc.

      Market size by Product
      HS-665
      CC-8464
      BLU-5937
      APD-371
      Others
      Market size by End User
      In-patient
      Out-patient

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Visceral Pain Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Visceral Pain Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Visceral Pain Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Visceral Pain Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Visceral Pain Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Visceral Pain Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now